Novelion Therapeutics Inc Revenue per Employee (NVLN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novelion Therapeutics Inc   (NVLN)
 

Novelion Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Novelion Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,008,567, below the company average number of $980,766.
Within the Healthcare sector Employees of 11 other companies have achieved higher revenue per employee. While Novelion Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 410. Novelion Therapeutics Inc has 134 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVLN Revenue per Employee (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Revenue Change 17.16 % 4.63 % 5.81 % -21.95 % -8.34 %
Sales per Employee (TTM) $ 1,008,567 973,373 959,925 947,500 1,014,463
NVLN's Total Ranking # 410 # 0 # 0 # 0 # 0
Seq. Revenue Change -20.9 % 34.21 % -4.92 % 16.08 % -29.36 %

NVLN Company Profile >> Back to NVLN Efficiency Comparisons >> Compare NVLN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 12
Overall Market # 410

Revenue per Employee Statistics
High Average Low
$ 1,014,463 $ 980,766 $ 947,500
(Mar 31 2018)   (Jun 30 2018)



Financial Statements
Novelion Therapeutics Inc 's Revenue MRQ $ 32 Millions Visit NVLN's Income Statement
Novelion Therapeutics Inc 's Revenues TTM $ 135 Millions Visit NVLN's aggregate revenue growth
What are NVLN's Sales? Visit NVLN's Sales by Segment




Other Ratios
Novelion Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NVLN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NVLN's Competitors
Revenue per Employee for NVLN's Suppliers
Revenue per Employee for NVLN's Customers

You may also want to know
NVLN's Sales Growth Rates NVLN's Pe Price to earnings ratio NVLN's Receivables Turnover Ratio NVLN's Stock Quote
NVLN's Net Income Growth Rates NVLN's Ps Price to Sales ratio NVLN's Sales per Employee NVLN's Asset Turnover Ratio
NVLN's Net Margin NVLN's Pb Price to Book ratio NVLN's Financial Strength Ratios NVLN's Dividend Payout Ratio
Date modified: 2026-09-08T15:09:34+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2019, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2019Number of Employees Mar 31 2019
Prestige Consumer Healthcare Inc   1,711,889.47 $ 975.777  Million 570 
Innoviva Inc   1,659,163.52 $ 263.807  Million 159 
Titan Pharmaceuticals Inc   1,624,750.00 $ 6.499  Million 4 
Puma Biotechnology Inc   1,584,033.52 $ 283.542  Million 179 
Kineta Inc   1,547,500.00 $ 6.190  Million 4 
Allergan plc  1,496,419.05 $ 15,712.400  Million 10,500 
Tvardi Therapeutics Inc   1,487,583.33 $ 17.851  Million 12 
Agenus Inc  1,420,235.21 $ 115.039  Million 81 
Applied Genetic Technologies Corporation  1,415,212.12 $ 46.702  Million 33 
Novaccess Global Inc  1,397,149.00 $ 1.397  Million 1 
Gilead Sciences Inc   1,312,941.18 $ 22,320.000  Million 17,000 
Sunwin Stevia International Inc.  1,303,152.81 $ 20.850  Million 16 
Cv Sciences Inc   1,251,914.43 $ 55.084  Million 44 
Akebia Therapeutics Inc   1,208,649.48 $ 234.478  Million 194 
Veru Inc   1,202,646.10 $ 24.053  Million 20 
Palvella Therapeutics Inc   1,154,965.52 $ 33.494  Million 29 
United Therapeutics Corporation  1,143,714.29 $ 1,601.200  Million 1,400 
Alexion Pharmaceuticals Inc   1,131,274.43 $ 4,340.700  Million 3,837 
Cytomx Therapeutics Inc   1,084,101.45 $ 74.803  Million 69 
Yunhong Green Cti Ltd   1,041,313.73 $ 54.148  Million 52 
Endo International Plc  1,012,269.53 $ 2,966.962  Million 2,931 
Novelion Therapeutics Inc   1,008,567.16 $ 135.148  Million 134 
Lifevantage Corp  1,003,681.61 $ 223.821  Million 223 
Surgalign Holdings Inc   989,365.08 $ 186.990  Million 189 
Qc Technologies Inc   987,609.00 $ 1.975  Million 2 
Horizon Therapeutics Public Limited Company  972,353.85 $ 1,264.060  Million 1,300 
Emergent Biosolutions Inc   950,206.67 $ 855.186  Million 900 
Xoma Royalty Corporation  926,214.29 $ 12.967  Million 14 
Prophase Labs Inc   801,210.53 $ 15.223  Million 19 
Forte Biosciences Inc   784,565.22 $ 18.045  Million 23 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.